Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The Company has developed an accurate, non-invasive, screening test for the early detection of colorectal pre-cancer and cancer. The Company’s Cologuard test is a non-invasive, stool-based deoxyribonucleic acid (DNA) (sDNA) screening test designed to detect DNA markers, which in published studies have been shown to be associated with colorectal cancer. In addition to DNA markers, its test includes a protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test (FIT). Its Cologuard test is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer.